Navigation Links
Telcyta in Medical News

Telik Presents Results at ASCO From ASSIST-5 Trial of TELCYTA in Platinum Refractory and Resistant Ovarian Cancer

PALO ALTO, Calif., May 31 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK ) today announced presentation at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida, of results from the ASSIST-5 Phase 3 randomized, multinational study of TELCYTA(...

Telik Announces Preclinical Presentations at AACR Annual Meeting

...iscovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Fourth Quarter and 2008 Year End Financial Results and 2009 Financial Guidance

.... Telik does not undertake any obligation to update forward-looking statements contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. Telik, Inc. St...

Telik Announces Year-End Financial Release, Conference Call and Webcast

...overy technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...
Telcyta in Medical Technology

Telik Announces Telcyta Clinical and Preclinical Presentations at AACR Meeting

PALO ALTO, Calif., April 09, 2007 /PRNewswire-FirstCall/ -- Telik, Inc. announced that updated clinical data from its multicenter Phase 2 trial of the triplet combination of TELCYTA(R) (canfosfamide HCl, TLK286), carboplatin and paclitaxel will be presented at the 98th annual meeting of the Americ...

Telik Reports Positive Data Demonstrating Synergy in Combination and Highly Statistically Significant Effect of Telcyta as Maintenance Therapy in First-Line Non-Small Cell Lung Cancer

PALO ALTO, Calif., April 17, 2007 /PRNewswire-FirstCall/ -- Telik, Inc. announced the presentation today of results from a Phase 2 clinical trial of the triplet combination of TELCYTA(R) (canfosfamide HCl, TLK286), carboplatin and paclitaxel in the first-line treatment of advanced non-small cell l...

Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome

...very technology, TRAP((R)), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Presentation at ASCO Annual Meeting

...iscovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies

...ik's results to differ materially from those indicated by these forward-looking statements, including, among others, if clinical trials of TELINTRA or telcyta are delayed or unsuccessful, Telik's business would suffer, if Telik's competitors develop and market products that are more effective than its produc...
Telcyta in Biological Technology

FDA Removes Partial Hold on TELCYTA Clinical Development

PALO ALTO, Calif., Oct. 15 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK ) announced that the U.S. Food and Drug Administration (FDA) has removed the partial hold on TELCYTA(R) (canfosfamide HCl, TLK286) clinical trials. This action follows a complete review of TELCYTA data by the agenc...

Telik Announces Second Quarter 2009 Financial Results

...king statements, including, among others, if clinical trials of TELINTRA or telcyta are delayed or unsuccessful, Telik's business would suffer, if Telik's comp...ts contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Reports Preclinical Results at AACR Annual Meeting

...iscovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Implements Reorganization to Focus Resources Toward Drug Development Pipeline

...iodic filings with the SEC. The Company does not undertake any obligation to update forward-looking statements. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Financial Results for 2008 Third Quarter

...2008. Telik does not undertake any obligation to update forward-looking statements contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. Telik, Inc. Statements of Op...

Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer

...ts from an interrupted Phase 3 randomized study of telcyta (canfosfamide HCL) in combination with pegylated l...gression-free survival (PFS) was 5.6 months on the telcyta plus PLD arm compared to 3.7 months on the PLD con...um resistant disease, including 40 patients on the telcyta plus PLD arm and 35 patients on the PLD control ar...

Telik Announces 2008 Third Quarter Financial Release, Conference Call and Webcast

...g discovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Financial Results For 2008 Second Quarter

...2008. Telik does not undertake any obligation to update forward-looking statements contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. Telik, Inc. Statements of O...

Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast

...g discovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces First Quarter 2008 Financial Results

...oking" statements, including statements regarding the future development of telcyta and TELINTRA. These forward-looking statements are based upon Telik's curre... forward-looking statements, including, among others, if clinical trials of telcyta or TELINTRA are delayed or unsuccessful, Telik's business would suffer, if ...
Other Tags
(Date:5/25/2013)... (PRWEB) May 25, 2013 On May 20, ... people do not wish to discuss or plan for their ... FuneralFinancials.com released a Must-Do List to help ... Funeral Financials recommends, “Creating a personal fact sheet.” , While ... organize financial information and personal data. It may include ...
(Date:5/25/2013)... York,NY (PRWEB) May 25, 2013 By ... officially declared the integration of the 2012 Lamborghini ... Aventador is the latest entrant in the list of ... intelligently, the vehicle is all set to thrill automobile ... vicious acceleration power and spectacular looks, the 2012 Lamborghini ...
(Date:5/25/2013)... Many orthodontists have thought about moving their ... cloud is. Most people would naturally assume that ... their cloud service and support would own and maintain ... selling, they'd be wrong. Cloud providers lease space ... facility that houses servers and related equipment to run ...
(Date:5/25/2013)... NJ (PRWEB) May 25, 2013 Acuity ... The universal app version of Word Hunt is ... versions of Concentration, Edge Match, Flash 2, Sudoku and Matchematics ... The brain games’ gameplay and revolutionary lifetime brain fitness measurement ... inch displays. , “100 years of brain fitness measurement in ...
(Date:5/25/2013)... Bradley, Illinois (PRWEB) May 25, 2013 ... assisted living community, is hosting an American Red Cross ... May 30. , The community, which is located at ... of all incomes, including those on Medicaid, who need ... give the Gift of Life," says Andrea Arview Frey, ...
Breaking Medicine News(10 mins):Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2Health News:Acuity Games Apps Come to the iPhone 2Health News:Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive 2
(Date:5/23/2013)... have succeeded in treating cerebral palsy with autologous cord ... a 2.5 year old boy had been in a ... Just two months after treatment with the cord blood ... following months, the child learned to speak simple sentences ... a Korean study, dispel the long-held doubts about the ...
(Date:5/23/2013)... MADISON, Wis. In an age when microbial pathogens ... to tamp down infection, a team of Wisconsin scientists ... of curbing the bacteria that cause staph infections. , ... Chemical Society , a group led by University of ... interfere with the "quorum sensing" behavior of Staphylococcus ...
(Date:5/22/2013)... technique that can detect molecular variants in chemical mixtures ... the most important, though time-consuming, processes in analytical chemistry. ... Nature , post-doctoral researcher David Patterson, Professor of Physics ... for Free-Electron Laser Science (CFEL) in Hamburg, Germany developed ... identify molecular variants apart, and to determine how much ...
Breaking Biology News(10 mins):First successful treatment of pediatric cerebral palsy with autologous cord blood 2University of Wisconsin chemists find new compounds to curb staph infection 2Detecting mirror molecules 2Detecting mirror molecules 3
Other Contents